Fiche du document
2013
- doi: 10.1371/journal.ppat.1003531
- issn: 1553-7366
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.1371/journal.ppat.1003531
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pmid/23935505
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/eissn/1553-7374
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_C93A98AB7B0B7
info:eu-repo/semantics/openAccess , Copying allowed only for non-profit organizations , https://serval.unil.ch/disclaimer
Sujets proches
Infectious diseasesCiter ce document
M.M. Zaiss et al., « IL-1β Suppresses Innate IL-25 and IL-33 Production and Maintains Helminth Chronicity. », Serveur académique Lausannois, ID : 10.1371/journal.ppat.1003531
Métriques
Partage / Export
Résumé
Approximately 2 billion people currently suffer from intestinal helminth infections, which are typically chronic in nature and result in growth retardation, vitamin A deficiency, anemia and poor cognitive function. Such chronicity results from co-evolution between helminths and their mammalian hosts; however, the molecular mechanisms by which these organisms avert immune rejection are not clear. We have found that the natural murine helminth, Heligmosomoides polygyrus bakeri (Hp) elicits the secretion of IL-1β in vivo and in vitro and that this cytokine is critical for shaping a mucosal environment suited to helminth chronicity. Indeed in mice deficient for IL-1β (IL-1β(-/-)), or treated with the soluble IL-1βR antagonist, Anakinra, helminth infection results in enhanced type 2 immunity and accelerated parasite expulsion. IL-1β acts to decrease production of IL-25 and IL-33 at early time points following infection and parasite rejection was determined to require IL-25. Taken together, these data indicate that Hp promotes the release of host-derived IL-1β that suppresses the release of innate cytokines, resulting in suboptimal type 2 immunity and allowing pathogen chronicity.